DOCSLIB.ORG

The Cervical Cancer Cell Lines Hela, Siha, and Caski

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Cervical Cancer Cell Lines Hela, Siha, and Caski The four hypoxia gene lists together with fold-change (Log2-transformed) of expression after hypoxia treatment in the cervical cancer cell lines HeLa, SiHa, and CaSki Hypoxia cervical up x3 Hypoxia cervical up & literature Hypoxia cervical down x3 Hypoxia cervical down & literature GeneSymbol HeLa SiHa CaSki GeneSymbol HeLa SiHa CaSki ABCA7 2.347 2.008 1.036 MLKL -1.298 -1.500 -1.089 ARID3A 1.369 3.040 1.256 NOL6 -2.084 -1.305 -1.543 C1ORF51 1.240 2.139 1.591 NOP2 -1.525 -1.531 -1.060 HIG2 2.781 2.185 2.158 PRMT3 -1.216 -1.084 -1.431 CMIP 1.190 1.003 1.130 ELOVL6 -1.743 -1.557 -1.490 FGF11 1.752 3.849 2.682 HSPH1 -1.796 -1.255 -1.002 FTH1P3 1.135 1.490 1.033 KIAA0020 -1.100 -1.184 -1.148 GPRC5C 1.011 4.025 1.307 LRP8 -1.099 -1.529 -1.248 HSF2BP 1.647 1.020 1.049 ODC1 -1.393 -1.578 -1.796 IRS2 1.552 1.128 1.352 VARS -1.772 -1.076 -1.125 LOC100008589 1.992 2.096 1.120 ABCF2 -1.129 -0.807 -0.725 LOC286016 2.431 1.532 1.232 ACOT7 0.125 -1.300 -0.933 LOC401152 2.016 2.262 1.810 ADAR -1.619 -0.198 -0.102 LOC441763 2.646 2.047 1.127 AIMP2 0.209 -1.330 -0.881 LOC644760 2.284 1.428 1.375 AMD1 -1.484 -0.639 -0.469 LOC644774 1.328 2.036 1.871 ANLN -1.210 -1.560 0.561 LOC645553 2.282 1.658 1.581 ATIC -1.036 -0.738 -0.834 LOC730525 1.548 1.646 1.668 ATP5G1 0.631 -1.445 -1.243 LOC732165 2.843 1.861 1.251 BCS1L -0.075 -1.010 -0.540 MALL 1.368 2.180 1.089 BOP1 -1.145 -0.863 -0.916 NMB 1.868 1.265 1.724 BRCA1 -0.006 -1.101 0.211 NUDT18 1.845 1.444 1.208 C12ORF48 -0.985 -1.219 -0.163 PGAM4 1.674 1.434 1.006 C17ORF80 -1.277 -0.462 -0.183 PIK3IP1 1.100 1.421 1.477 C1ORF135 0.187 -1.500 -0.493 SLPI 2.428 1.183 1.230 C1ORF163 -0.086 -1.042 -0.894 TMEM145 1.029 2.401 1.514 C20ORF27 0.405 -1.387 -0.368 TMEM158 1.044 1.249 1.238 CAD -0.761 -1.093 -0.449 TNNT1 1.835 1.628 1.107 CALD1 -1.040 0.595 0.297 VKORC1 2.453 1.792 1.373 CALM1 -1.207 0.078 0.015 ADM 2.973 2.359 1.489 CAPRIN1 -1.580 -0.417 -0.432 AK3L1 2.063 2.590 1.208 CBX6 -1.918 -0.278 -0.426 ALDOA 1.690 1.475 1.132 CCDC86 -0.680 -0.405 -1.109 ALDOC 4.288 3.918 1.793 CCDC99 -0.432 -1.171 -0.089 ANG 3.058 2.225 2.283 CCNA2 -0.759 -2.159 -0.416 ANKRD37 3.809 3.731 2.380 CCND1 -2.287 -0.046 -1.584 ANKZF1 1.881 1.781 1.406 CCND3 -1.286 -1.117 -0.457 BHLHB2 1.010 1.540 1.752 CCNF -1.695 -1.787 -0.168 BNIP3 3.299 3.392 2.598 CCT6A -1.337 -0.755 -0.723 BNIP3L 2.044 3.613 2.839 CDC2 0.064 -1.654 -0.063 BTG1 1.754 1.455 1.556 CDC20 -0.958 -2.065 -0.514 CA9 5.977 6.104 4.825 CDCA4 0.908 -1.040 0.070 Cervix cancer hypoxia gene sets p1 CCNG2 1.247 1.252 1.149 CENPF -1.248 -1.798 0.016 CDKN1A 1.109 1.595 1.043 CENPN 0.917 -1.019 -0.002 DDIT4 1.750 2.234 3.578 CNOT7 -1.130 0.122 0.031 EGLN1 1.484 1.323 1.307 COL18A1 -1.254 0.106 0.117 EGLN3 1.561 2.161 1.388 CORO1C -1.019 0.396 -0.122 ENO2 2.870 2.553 2.797 CSDE1 -1.096 -0.145 -0.429 ERRFI1 2.967 1.389 2.106 CSE1L -1.255 -1.115 -0.763 FAM162A 2.850 2.294 2.033 CTPS -0.962 -1.048 -0.897 GAPDH 1.072 1.277 1.072 CYTSA -1.050 0.120 0.364 GPI 1.627 1.427 1.374 DDX23 -1.297 -0.695 -0.305 HCFC1R1 2.269 1.333 1.082 DDX3X -1.320 0.261 0.206 HK2 1.782 3.158 1.346 DHCR24 -1.102 -0.517 -0.323 IGFBP3 3.043 3.780 2.288 DHX29 -1.190 -0.536 -0.533 INSIG2 1.831 2.272 2.012 DLAT -1.222 -0.123 -0.482 JMJD1A 1.064 1.763 1.592 EEF2 -1.349 0.669 0.305 KCTD11 1.244 1.842 1.925 EFEMP1 -1.215 -0.783 -0.609 LOX 1.890 4.247 2.822 EFTUD2 -1.033 -0.505 -0.446 MUC1 1.335 2.392 2.193 ERCC6L -0.576 -1.556 -0.357 NDRG1 3.436 3.424 3.953 EXO1 -0.290 -2.210 -0.193 P4HA1 1.870 2.587 2.051 FANCG -0.260 -1.046 -0.127 P4HA2 1.840 2.805 1.544 FANCI -1.087 -1.405 0.175 PFKFB4 2.657 3.671 3.575 FASN -1.587 -0.899 -0.930 PGAM1 1.422 1.527 1.128 FASTKD5 -1.196 -0.539 -0.489 PGK1 1.444 1.986 1.867 FBXO5 0.093 -1.301 0.182 PLOD2 1.456 2.232 2.103 FEN1 0.316 -1.146 -0.151 PPFIA4 2.129 2.214 1.783 FGF2 -1.315 0.002 -0.179 PTPRR 1.281 1.040 1.325 GART -0.728 -1.122 -0.666 RNASE4 2.273 2.595 2.358 GINS3 0.101 -1.234 -0.046 RNF24 1.143 1.574 1.094 GLRX2 0.586 -1.086 -0.081 SH3GL3 1.747 2.739 1.548 GMFB -1.598 -0.047 0.058 SPRY1 1.996 2.727 2.146 GNA13 -1.044 0.237 0.341 STC2 2.540 4.348 2.824 GNPDA1 -1.011 -0.348 -0.765 TMEM45A 3.846 3.741 2.560 GPD1L -1.423 -0.761 -0.754 TPI1 1.617 1.254 1.016 GPR56 -1.196 -0.299 -0.211 VLDLR 1.869 2.711 1.762 GULP1 -1.058 -0.236 -0.196 WDR54 2.383 1.816 1.126 H2AFX 0.771 -1.253 -0.021 YPEL5 1.146 1.687 1.374 HEATR1 -1.799 -0.753 -0.503 ZNF395 2.073 2.886 1.569 HIF1A -1.006 0.596 0.146 ABCA1 -0.566 1.133 1.038 HJURP 0.120 -1.879 -0.078 ABCB6 0.513 1.258 0.975 HMBS 0.457 -1.329 -0.659 ADORA2B 1.560 1.459 -0.602 HSPA1A -1.351 -0.459 -0.610 AK2 1.090 0.429 0.122 HSPA1B -1.255 -0.478 -0.393 ANGPTL4 0.776 3.486 3.613 HSPA4 -1.137 -0.197 -0.328 ANKRD9 1.323 0.985 0.218 HSPC111 0.522 -1.183 -1.208 AOX1 0.728 1.718 -0.006 HSPD1 -1.005 -0.604 -0.761 APITD1 1.096 -0.691 -0.139 HSPE1 -0.209 -0.650 -1.042 ARRDC3 0.009 1.491 1.208 IARS -1.211 -0.657 0.210 ATF3 0.906 0.413 1.158 IDE -1.688 -0.756 -0.574 ATP1B1 1.084 1.413 0.098 IDH3A -1.135 -0.246 -0.920 ATP5O 1.132 -0.005 0.026 KIF23 -1.138 -1.985 -0.259 Cervix cancer hypoxia gene sets p2 AXL -0.567 1.397 0.282 KIF4A -0.425 -1.507 0.195 B3GNT4 0.338 1.955 0.305 KIAA0101 0.967 -1.571 -0.016 BAX 1.735 -0.341 0.300 KIAA0564 -1.168 -0.249 -0.024 BIK 0.651 1.866 1.428 KPNA4 -1.243 -0.268 -0.209 BLVRB 1.053 0.049 0.395 LARP4 -1.457 -0.185 -0.342 BOLA2 1.497 -0.647 -0.404 LARS2 -1.173 -0.350 -0.321 C10ORF10 -0.038 0.142 1.493 LDLR -1.288 -1.117 -0.527 C12ORF24 1.243 1.066 -0.122 LETM1 -1.272 -0.711 -0.283 C14ORF2 1.088 -0.073 -0.307 MAD2L1 0.132 -1.428 -0.372 C16ORF74 1.218 1.213 0.157 MCL1 -1.098 -0.925 -0.564 C19ORF53 1.285 -0.399 -0.252 MCM10 0.290 -1.317 0.082 C3ORF10 1.503 1.172 0.514 MELK 0.047 -1.760 0.152 C5ORF13 0.334 1.683 0.655 MEST -1.412 -0.344 -1.058 CA12 1.678 3.304 0.067 MNS1 0.403 -1.627 -0.342 CAV1 0.841 1.166 0.571 MPHOSPH9 -1.160 -1.078 -0.184 CD99 1.715 0.817 0.275 MRTO4 0.337 -0.766 -1.027 CDC2L6 -0.068 1.102 0.968 NARS -1.019 -0.554 -0.062 CDKN1C 2.384 0.260 0.569 NAT10 -1.292 0.384 -0.703 CEBPB -0.101 0.026 1.001 NCAPG2 -0.380 -1.386 0.149 CEBPD 1.443 0.538 -0.132 NFKB1 -1.400 -0.366 -0.056 CECR5 0.929 1.015 0.189 NME1 0.496 -0.794 -1.216 CFD 2.469 0.979 0.227 NMT1 -1.732 0.027 -0.234 CHSY1 -0.233 1.734 0.291 NOL11 -1.415 -0.646 -0.621 CITED2 1.169 1.802 0.705 NOL12 0.073 -1.151 -0.245 CKB 1.890 0.588 0.008 NOLC1 -1.484 -1.202 -0.683 CNOT8 0.670 1.084 0.522 NOP56 -0.055 -1.156 -0.896 COL5A1 -0.435 1.433 1.274 NUP160 -1.471 -0.682 -0.277 CRLF1 1.139 0.325 -0.179 NUP205 -1.094 -0.659 -0.373 CSNK2B 1.350 -0.076 0.041 NUP85 -0.195 -1.014 -0.050 CSRP2 1.666 0.831 0.877 NUSAP1 -0.421 -1.484 0.059 CXCR4 1.263 -0.103 -0.226 OIP5 0.708 -1.344 -0.251 CXCR7 0.862 1.242 0.019 ORC6L 0.491 -1.937 -0.195 CYB5A 1.006 -0.386 -0.263 PA2G4 0.537 -1.312 -0.524 DDIT3 1.510 0.383 1.210 PARP1 -1.243 -0.107 -0.436 DDX41 0.771 1.371 0.448 PARP2 0.079 -1.158 -0.138 DPM2 1.172 -0.236 -0.081 PBK -0.062 -1.564 -0.500 DPYSL2 0.402 0.634 1.053 PCYT2 -0.138 -1.118 -0.410 DPYSL4 -0.368 2.636 -0.001 PER3 -0.558 -1.166 -0.007 DUSP1 0.912 1.460 0.351 PFAS -1.751 -0.950 -0.896 EBP 1.232 -0.958 0.128 PKMYT1 0.817 -2.080 0.241 EBPL 1.350 0.483 -0.352 POLA2 -0.547 -1.209 -0.064 ECE2 1.042 0.292 -0.382 POLE2 0.201 -1.336 -0.409 EDN2 3.570 4.209 0.234 PPARG -0.776 -1.137 -1.003 EFNA1 0.979 1.167 0.199 PPAT -1.019 -0.274 -0.728 EIF1B 1.146 -0.204 -0.007 PRC1 -0.925 -2.004 0.037 ELF3 0.644 1.000 0.234 PSMC3IP 0.968 -1.311 -0.051 ELL2 -0.211 1.121 0.347 PSME3 -1.137 -0.291 -0.746 EMP3 1.520 0.523 0.130 PSME4 -1.482 -0.209 -0.411 EPOR 1.192 0.579 0.195 PSMG1 0.414 -1.022 -0.234 ERO1L 0.366 1.651 1.200 RAD51AP1 -0.175 -1.706 0.160 Cervix cancer hypoxia gene sets p3 EXOSC8 1.014 -0.851 0.010 RAI14 -1.110 -0.506 -0.564 FABP5 1.064 -0.677 -0.571 RANBP1 0.483 -1.052 -0.555 FAM119B 0.455 2.121 0.188 RANGAP1 -1.780 -1.127 -0.093 FAM13A 0.477 1.480 0.405 RBM12 -1.059 -0.525 -0.595 FAM46A -0.150 0.863 1.220 RFC3 -0.610 -1.683 -0.449 FER1L4 -0.342 1.610 -0.702 RFC5 0.099 -1.121 -0.208 FLNB 0.336 0.889 1.217 RNF14 -1.102 -0.035 0.054 FOS -0.885 1.942 -0.125 RPP40 0.377 -1.140 -1.085 FOXD1 1.943 1.495 0.117 RRM1 -0.622 -1.108 -0.228 FOXO3 0.077 1.109 0.200 RRM2 -0.206 -2.346 -0.141 GADD45B 1.261 0.867 0.701 RRP1B -1.065 0.003 -0.282 GBE1 0.914 2.877 1.318 RRP9 -0.423 -0.799 -1.240 GLRX 1.662 1.357 0.792 RRS1 -0.136 -1.356 -1.362 GLS -0.019 1.196 0.402 SCD -1.111 0.357 0.555 GPRC5A 1.506 1.491 0.762 SEH1L -1.198 -0.338 -0.473 GRSF1 -0.572 1.387 0.104 SEL1L3 -1.208 -0.360 0.279 GYS1 0.988 1.636 0.751 SFRS1 -1.127 -0.649 -0.477 HBP1 0.450 1.129 0.793 SIP1 0.236 -1.039 -0.523 HERC3 0.400 1.098 0.483 SKP2 -0.960 -1.096 -1.221 HERPUD1 1.091 0.650 0.996 SLC11A2 -1.308 0.056 -0.553 HLA-B 1.698 1.426 0.340 SLC25A44 -1.506 -0.335 -0.162 HLA-DQB1 0.023 3.361 0.180 SLC5A6 -1.374 -1.096 -0.822 HLA-DRB1 0.183 2.991 -0.030 SQLE -0.603 -1.022 -0.209 HMHA1 -0.254 1.168 0.880 SRM 0.339 -0.793 -1.180 HMOX1 0.906 1.092 1.799 STIL -1.009 -1.678 0.169 HOMER1 -0.334 1.193 -0.080 TFRC -1.022 0.889 -0.568 HSPA5 -0.478 1.610 -0.014 THBS1 -1.017 0.369 -0.129 ID1 1.720 0.294 -0.424 TIPIN 0.079 -0.888 -1.095 ID2 1.955 0.309 0.528 TMTC3 -1.577 -0.162 -0.211 IDH2 1.901 0.384 0.608 TPX2 -1.318 -2.036 0.195 IER3 2.286 2.491 0.987 TRIOBP 0.040 -1.082 -0.213 IGFBP2 1.066 -0.114 0.108 TRIP13 -0.193 -1.838 -0.554 IGFBP5 1.111 2.282 -0.673 TRMT5 0.064 -1.216 -0.230 IGFBP7 1.311 0.253 0.408 TSEN2 -1.032 -0.775 -1.046 ILVBL 0.189 1.214 0.709 TUBB2C 0.240 -1.179 -0.138 IMMP2L 1.278 0.839 -0.101 TUBG1 0.434 -1.208 -0.149 IMP3 1.238 0.774 0.473 TUBGCP4 -1.057 -0.406 -0.497 INHBE 1.329 0.061 0.094 VWF -1.155 0.167
Load more

Recommended publications
  • Computational Genome-Wide Identification of Heat Shock Protein Genes in the Bovine Genome [Version 1; Peer Review: 2 Approved, 1 Approved with Reservations]
    F1000Research 2018, 7:1504 Last updated: 08 AUG 2021 RESEARCH ARTICLE Computational genome-wide identification of heat shock protein genes in the bovine genome [version 1; peer review: 2 approved, 1 approved with reservations] Oyeyemi O. Ajayi1,2, Sunday O. Peters3, Marcos De Donato2,4, Sunday O. Sowande5, Fidalis D.N. Mujibi6, Olanrewaju B. Morenikeji2,7, Bolaji N. Thomas 8, Matthew A. Adeleke 9, Ikhide G. Imumorin2,10,11 1Department of Animal Breeding and Genetics, Federal University of Agriculture, Abeokuta, Nigeria 2International Programs, College of Agriculture and Life Sciences, Cornell University, Ithaca, NY, 14853, USA 3Department of Animal Science, Berry College, Mount Berry, GA, 30149, USA 4Departamento Regional de Bioingenierias, Tecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Queretaro, Mexico 5Department of Animal Production and Health, Federal University of Agriculture, Abeokuta, Nigeria 6Usomi Limited, Nairobi, Kenya 7Department of Animal Production and Health, Federal University of Technology, Akure, Nigeria 8Department of Biomedical Sciences, Rochester Institute of Technology, Rochester, NY, 14623, USA 9School of Life Sciences, University of KwaZulu-Natal, Durban, 4000, South Africa 10School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, 30032, USA 11African Institute of Bioscience Research and Training, Ibadan, Nigeria v1 First published: 20 Sep 2018, 7:1504 Open Peer Review https://doi.org/10.12688/f1000research.16058.1 Latest published: 20 Sep 2018, 7:1504 https://doi.org/10.12688/f1000research.16058.1 Reviewer Status Invited Reviewers Abstract Background: Heat shock proteins (HSPs) are molecular chaperones 1 2 3 known to bind and sequester client proteins under stress. Methods: To identify and better understand some of these proteins, version 1 we carried out a computational genome-wide survey of the bovine 20 Sep 2018 report report report genome.
    [Show full text]
  • Organ Level Protein Networks As a Reference for the Host Effects of the Microbiome
    Downloaded from genome.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press 1 Organ level protein networks as a reference for the host effects of the microbiome 2 3 Robert H. Millsa,b,c,d, Jacob M. Wozniaka,b, Alison Vrbanacc, Anaamika Campeaua,b, Benoit 4 Chassainge,f,g,h, Andrew Gewirtze, Rob Knightc,d, and David J. Gonzaleza,b,d,# 5 6 a Department of Pharmacology, University of California, San Diego, California, USA 7 b Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, 8 California, USA 9 c Department of Pediatrics, and Department of Computer Science and Engineering, University of 10 California, San Diego California, USA 11 d Center for Microbiome Innovation, University of California, San Diego, California, USA 12 e Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State 13 University, Atlanta, GA, USA 14 f Neuroscience Institute, Georgia State University, Atlanta, GA, USA 15 g INSERM, U1016, Paris, France. 16 h Université de Paris, Paris, France. 17 18 Key words: Microbiota, Tandem Mass Tags, Organ Proteomics, Gnotobiotic Mice, Germ-free Mice, 19 Protein Networks, Proteomics 20 21 # Address Correspondence to: 22 David J. Gonzalez, PhD 23 Department of Pharmacology and Pharmacy 24 University of California, San Diego 25 La Jolla, CA 92093 26 E-mail: [email protected] 27 Phone: 858-822-1218 28 1 Downloaded from genome.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press 29 Abstract 30 Connections between the microbiome and health are rapidly emerging in a wide range of 31 diseases.
    [Show full text]
  • Defining Functional Interactions During Biogenesis of Epithelial Junctions
    ARTICLE Received 11 Dec 2015 | Accepted 13 Oct 2016 | Published 6 Dec 2016 | Updated 5 Jan 2017 DOI: 10.1038/ncomms13542 OPEN Defining functional interactions during biogenesis of epithelial junctions J.C. Erasmus1,*, S. Bruche1,*,w, L. Pizarro1,2,*, N. Maimari1,3,*, T. Poggioli1,w, C. Tomlinson4,J.Lees5, I. Zalivina1,w, A. Wheeler1,w, A. Alberts6, A. Russo2 & V.M.M. Braga1 In spite of extensive recent progress, a comprehensive understanding of how actin cytoskeleton remodelling supports stable junctions remains to be established. Here we design a platform that integrates actin functions with optimized phenotypic clustering and identify new cytoskeletal proteins, their functional hierarchy and pathways that modulate E-cadherin adhesion. Depletion of EEF1A, an actin bundling protein, increases E-cadherin levels at junctions without a corresponding reinforcement of cell–cell contacts. This unexpected result reflects a more dynamic and mobile junctional actin in EEF1A-depleted cells. A partner for EEF1A in cadherin contact maintenance is the formin DIAPH2, which interacts with EEF1A. In contrast, depletion of either the endocytic regulator TRIP10 or the Rho GTPase activator VAV2 reduces E-cadherin levels at junctions. TRIP10 binds to and requires VAV2 function for its junctional localization. Overall, we present new conceptual insights on junction stabilization, which integrate known and novel pathways with impact for epithelial morphogenesis, homeostasis and diseases. 1 National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK. 2 Computing Department, Imperial College London, London SW7 2AZ, UK. 3 Bioengineering Department, Faculty of Engineering, Imperial College London, London SW7 2AZ, UK. 4 Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Figure S1. HAEC ROS Production and ML090 NOX5-Inhibition
    Figure S1. HAEC ROS production and ML090 NOX5-inhibition. (a) Extracellular H2O2 production in HAEC treated with ML090 at different concentrations and 24 h after being infected with GFP and NOX5-β adenoviruses (MOI 100). **p< 0.01, and ****p< 0.0001 vs control NOX5-β-infected cells (ML090, 0 nM). Results expressed as mean ± SEM. Fold increase vs GFP-infected cells with 0 nM of ML090. n= 6. (b) NOX5-β overexpression and DHE oxidation in HAEC. Representative images from three experiments are shown. Intracellular superoxide anion production of HAEC 24 h after infection with GFP and NOX5-β adenoviruses at different MOIs treated or not with ML090 (10 nM). MOI: Multiplicity of infection. Figure S2. Ontology analysis of HAEC infected with NOX5-β. Ontology analysis shows that the response to unfolded protein is the most relevant. Figure S3. UPR mRNA expression in heart of infarcted transgenic mice. n= 12-13. Results expressed as mean ± SEM. Table S1: Altered gene expression due to NOX5-β expression at 12 h (bold, highlighted in yellow). N12hvsG12h N18hvsG18h N24hvsG24h GeneName GeneDescription TranscriptID logFC p-value logFC p-value logFC p-value family with sequence similarity NM_052966 1.45 1.20E-17 2.44 3.27E-19 2.96 6.24E-21 FAM129A 129. member A DnaJ (Hsp40) homolog. NM_001130182 2.19 9.83E-20 2.94 2.90E-19 3.01 1.68E-19 DNAJA4 subfamily A. member 4 phorbol-12-myristate-13-acetate- NM_021127 0.93 1.84E-12 2.41 1.32E-17 2.69 1.43E-18 PMAIP1 induced protein 1 E2F7 E2F transcription factor 7 NM_203394 0.71 8.35E-11 2.20 2.21E-17 2.48 1.84E-18 DnaJ (Hsp40) homolog.
    [Show full text]
  • Identification of Transcriptional Mechanisms Downstream of Nf1 Gene Defeciency in Malignant Peripheral Nerve Sheath Tumors Daochun Sun Wayne State University
    Wayne State University DigitalCommons@WayneState Wayne State University Dissertations 1-1-2012 Identification of transcriptional mechanisms downstream of nf1 gene defeciency in malignant peripheral nerve sheath tumors Daochun Sun Wayne State University, Follow this and additional works at: http://digitalcommons.wayne.edu/oa_dissertations Recommended Citation Sun, Daochun, "Identification of transcriptional mechanisms downstream of nf1 gene defeciency in malignant peripheral nerve sheath tumors" (2012). Wayne State University Dissertations. Paper 558. This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState. IDENTIFICATION OF TRANSCRIPTIONAL MECHANISMS DOWNSTREAM OF NF1 GENE DEFECIENCY IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS by DAOCHUN SUN DISSERTATION Submitted to the Graduate School of Wayne State University, Detroit, Michigan in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY 2012 MAJOR: MOLECULAR BIOLOGY AND GENETICS Approved by: _______________________________________ Advisor Date _______________________________________ _______________________________________ _______________________________________ © COPYRIGHT BY DAOCHUN SUN 2012 All Rights Reserved DEDICATION This work is dedicated to my parents and my wife Ze Zheng for their continuous support and understanding during the years of my education. I could not achieve my goal without them. ii ACKNOWLEDGMENTS I would like to express tremendous appreciation to my mentor, Dr. Michael Tainsky. His guidance and encouragement throughout this project made this dissertation come true. I would also like to thank my committee members, Dr. Raymond Mattingly and Dr. John Reiners Jr. for their sustained attention to this project during the monthly NF1 group meetings and committee meetings, Dr.
    [Show full text]
  • Protein Homeostasis, Second Edition
    This is a free sample of content from Protein Homeostasis, Second Edition. Click here for more information on how to buy the book. Index A overview of diseases, 13, 41–43 Abf2, 160 polyphosphate AD. See Alzheimer’s disease amyloidogenic protein interactions, 393–395 AFG3L2, 162 cytotoxicity amelioration, 396–397 Africa swine fever virus (ASFV), 468 prospects for study, 52, 55 Aging protein homeostasis context, 48–49 heat shock factors, 431 structure–activity relationship, 14–15 proteostasis network regulation, 450–452 therapeutic intervention, 50–52 Ago2, 335, 467 toxicity, 47–48 Aha1, 333, 335, 338–339, 504 Amyotrophic lateral sclerosis (ALS), 214, 262, 264, AIRAP, 267 290–291, 293, 404, 409, 524, 532 AIRAPL, 267–268 ApoB, 135 AKT, 274, 467 ASFV. See Africa swine fever virus ALK, 503 ATAD1, 104 ALMC2, 487 ATF4, 79, 88, 182, 186, 189, 445–446 ALP. See Autophagy lysosome pathway ATF5, 182, 186, 189 a-Synuclein, 375, 522 ATF6, 60, 62–64, 79, 445–446, 481–482, 484–489 ALS. See Amyotrophic lateral sclerosis ATFS-1, 99, 180–181, 185, 188–189, 445–446 Alzheimer’s disease (AD), 186, 519 Atg7, 293 autophagy lysosomal pathway, 290–291 Atg32, 167 chaperone studies, 213–214, 216–217, 222 ATM, 313 Hsp90 studies, 337 ATR, 313 polyphosphate studies, 392, 394–395, 399 Atropine, 501 AMPK, 444 ATXN2, 524 Amyloid Autophagy lysosome pathway (ALP) chaperone modulation chaperone-mediated autophagy, 288–289 aggregation prevention, 217–222 history of study, 285 degradation of amyloid-forming proteins, 225–227 macroautophagy, 287–288 disaggregation of amyloids,
    [Show full text]
  • The HSP70 Chaperone Machinery: J Proteins As Drivers of Functional Specificity
    REVIEWS The HSP70 chaperone machinery: J proteins as drivers of functional specificity Harm H. Kampinga* and Elizabeth A. Craig‡ Abstract | Heat shock 70 kDa proteins (HSP70s) are ubiquitous molecular chaperones that function in a myriad of biological processes, modulating polypeptide folding, degradation and translocation across membranes, and protein–protein interactions. This multitude of roles is not easily reconciled with the universality of the activity of HSP70s in ATP-dependent client protein-binding and release cycles. Much of the functional diversity of the HSP70s is driven by a diverse class of cofactors: J proteins. Often, multiple J proteins function with a single HSP70. Some target HSP70 activity to clients at precise locations in cells and others bind client proteins directly, thereby delivering specific clients to HSP70 and directly determining their fate. In their native cellular environment, polypeptides are participates in such diverse cellular functions. Their constantly at risk of attaining conformations that pre- functional diversity is remarkable considering that vent them from functioning properly and/or cause them within and across species, HSP70s have high sequence to aggregate into large, potentially cytotoxic complexes. identity. They share a single biochemical activity: an Molecular chaperones guide the conformation of proteins ATP-dependent client-binding and release cycle com- throughout their lifetime, preventing their aggregation bined with client protein recognition, which is typi- by protecting interactive surfaces against non-productive cally rather promiscuous. This apparent conundrum interactions. Through such inter actions, molecular chap- is resolved by the fact that HSP70s do not work alone, erones aid in the folding of nascent proteins as they are but rather as ‘HSP70 machines’, collaborating with synthesized by ribosomes, drive protein transport across and being regulated by several cofactors.
    [Show full text]
  • Senescence Inhibits the Chaperone Response to Thermal Stress
    SUPPLEMENTAL INFORMATION Senescence inhibits the chaperone response to thermal stress Jack Llewellyn1, 2, Venkatesh Mallikarjun1, 2, 3, Ellen Appleton1, 2, Maria Osipova1, 2, Hamish TJ Gilbert1, 2, Stephen M Richardson2, Simon J Hubbard4, 5 and Joe Swift1, 2, 5 (1) Wellcome Centre for Cell-Matrix Research, Oxford Road, Manchester, M13 9PT, UK. (2) Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK. (3) Current address: Department of Biomedical Engineering, University of Virginia, Box 800759, Health System, Charlottesville, VA, 22903, USA. (4) Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK. (5) Correspondence to SJH ([email protected]) or JS ([email protected]). Page 1 of 11 Supplemental Information: Llewellyn et al. Chaperone stress response in senescence CONTENTS Supplemental figures S1 – S5 … … … … … … … … 3 Supplemental table S6 … … … … … … … … 10 Supplemental references … … … … … … … … 11 Page 2 of 11 Supplemental Information: Llewellyn et al. Chaperone stress response in senescence SUPPLEMENTAL FIGURES Figure S1. A EP (passage 3) LP (passage 16) 200 µm 200 µm 1.5 3 B Mass spectrometry proteomics (n = 4) C mRNA (n = 4) D 100k EP 1.0 2 p < 0.0001 p < 0.0001 LP p < 0.0001 p < 0.0001 ) 0.5 1 2 p < 0.0001 p < 0.0001 10k 0.0 0 -0.5 -1 Cell area (µm Cell area fold change vs. EP fold change vs.
    [Show full text]
  • Prognostic and Functional Significant of Heat Shock Proteins (Hsps)
    biology Article Prognostic and Functional Significant of Heat Shock Proteins (HSPs) in Breast Cancer Unveiled by Multi-Omics Approaches Miriam Buttacavoli 1,†, Gianluca Di Cara 1,†, Cesare D’Amico 1, Fabiana Geraci 1 , Ida Pucci-Minafra 2, Salvatore Feo 1 and Patrizia Cancemi 1,2,* 1 Department of Biological Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, 90128 Palermo, Italy; [email protected] (M.B.); [email protected] (G.D.C.); [email protected] (C.D.); [email protected] (F.G.); [email protected] (S.F.) 2 Experimental Center of Onco Biology (COBS), 90145 Palermo, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-091-2389-7330 † These authors contributed equally to this work. Simple Summary: In this study, we investigated the expression pattern and prognostic significance of the heat shock proteins (HSPs) family members in breast cancer (BC) by using several bioinfor- matics tools and proteomics investigations. Our results demonstrated that, collectively, HSPs were deregulated in BC, acting as both oncogene and onco-suppressor genes. In particular, two different HSP-clusters were significantly associated with a poor or good prognosis. Interestingly, the HSPs deregulation impacted gene expression and miRNAs regulation that, in turn, affected important bio- logical pathways involved in cell cycle, DNA replication, and receptors-mediated signaling. Finally, the proteomic identification of several HSPs members and isoforms revealed much more complexity Citation: Buttacavoli, M.; Di Cara, of HSPs roles in BC and showed that their expression is quite variable among patients. In conclusion, G.; D’Amico, C.; Geraci, F.; we elaborated two panels of HSPs that could be further explored as potential biomarkers for BC Pucci-Minafra, I.; Feo, S.; Cancemi, P.
    [Show full text]
  • Characterization of the Dual Functional Effects of Heat Shock Proteins (Hsps
    Zhang et al. Genome Medicine (2020) 12:101 https://doi.org/10.1186/s13073-020-00795-6 RESEARCH Open Access Characterization of the dual functional effects of heat shock proteins (HSPs) in cancer hallmarks to aid development of HSP inhibitors Zhao Zhang1†, Ji Jing2†, Youqiong Ye1, Zhiao Chen1, Ying Jing1, Shengli Li1, Wei Hong1, Hang Ruan1, Yaoming Liu1, Qingsong Hu3, Jun Wang4, Wenbo Li1, Chunru Lin3, Lixia Diao5*, Yubin Zhou2* and Leng Han1* Abstract Background: Heat shock proteins (HSPs), a representative family of chaperone genes, play crucial roles in malignant progression and are pursued as attractive anti-cancer therapeutic targets. Despite tremendous efforts to develop anti-cancer drugs based on HSPs, no HSP inhibitors have thus far reached the milestone of FDA approval. There remains an unmet need to further understand the functional roles of HSPs in cancer. Methods: We constructed the network for HSPs across ~ 10,000 tumor samples from The Cancer Genome Atlas (TCGA) and ~ 10,000 normal samples from Genotype-Tissue Expression (GTEx), and compared the network disruption between tumor and normal samples. We then examined the associations between HSPs and cancer hallmarks and validated these associations from multiple independent high-throughput functional screens, including Project Achilles and DRIVE. Finally, we experimentally characterized the dual function effects of HSPs in tumor proliferation and metastasis. Results: We comprehensively analyzed the HSP expression landscape across multiple human cancers and revealed a global disruption of the co-expression network for HSPs. Through analyzing HSP expression alteration and its association with tumor proliferation and metastasis, we revealed dual functional effects of HSPs, in that they can simultaneously influence proliferation and metastasis in opposite directions.
    [Show full text]
  • Mutant Uromodulin Expression Leads to Altered Homeostasis of the Endoplasmic Reticulum and Activates the Unfolded Protein Response
    RESEARCH ARTICLE Mutant uromodulin expression leads to altered homeostasis of the endoplasmic reticulum and activates the unfolded protein response CeÂline Schaeffer1, Stefania Merella2, Elena Pasqualetto1, Dejan Lazarevic2, Luca Rampoldi1* a1111111111 1 Molecular Genetics of Renal Disorders, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy, 2 Center of Translational Genomics and Bioinformatics, IRCCS San Raffaele a1111111111 Scientific Institute, Milan, Italy a1111111111 a1111111111 * [email protected] a1111111111 Abstract Uromodulin is the most abundant urinary protein in physiological conditions. It is exclusively OPEN ACCESS produced by renal epithelial cells lining the thick ascending limb of Henle's loop (TAL) and it Citation: Schaeffer C, Merella S, Pasqualetto E, plays key roles in kidney function and disease. Mutations in UMOD, the gene encoding uro- Lazarevic D, Rampoldi L (2017) Mutant uromodulin expression leads to altered modulin, cause autosomal dominant tubulointerstitial kidney disease uromodulin-related homeostasis of the endoplasmic reticulum and (ADTKD-UMOD), characterised by hyperuricemia, gout and progressive loss of renal func- activates the unfolded protein response. PLoS ONE tion. While the primary effect of UMOD mutations, retention in the endoplasmic reticulum 12(4): e0175970. https://doi.org/10.1371/journal. (ER), is well established, its downstream effects are still largely unknown. To gain insight pone.0175970 into ADTKD-UMOD pathogenesis, we performed transcriptional profiling and biochemical Editor: Salvatore V. Pizzo, Duke University School characterisation of cellular models (immortalised mouse TAL cells) of robust expression of of Medicine, UNITED STATES wild type or mutant GFP-tagged uromodulin. In this model mutant uromodulin accumulation Received: January 5, 2017 in the ER does not impact on cell viability and proliferation.
    [Show full text]